Skip to main content

Advanced keyword and structure searches with SureChEMBL


Previously in the SureChEMBL series, we described how to access SureChEMBL data in bulk, offline and locally. So, you may ask, what is the point in using the SureChEMBL web interface? Well, how about the unprecedented functionality that allows you to submit very granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus - at the same time?

Let’s see each one separately first:

Lucene-powered keyword searching

You may use the main text box for simple keyword-based patent searches, such as ‘Apple’, ‘diabetes’ or even 'chocolate cake' (the patent corpus as a recipe book is a new use-case here). You will get a lot of results and probably a lot of noise. With Lucene fields, you can slice and dice a query by indicating specific patent sections and bibliographic metadata, such as date/year of filing or publication, assignee, patent classification code, patent authority, etc. For example, to search for the term ‘diabetes’ only in the abstract of patents, you can search with:
ab:diabetes

where ab is the Lucene query field for abstract. For a full list of Lucene queries, see here. Furthermore, you can combine these fields with boolean operators (AND, OR, NOT - always in UPPER case) and brackets. For example to find US patents published in 2014 which also mention the word ‘diabetes’ in the title or abstract, you could search with:

(ttl:diabetes OR ab:diabetes) AND pdyear:2014 AND pnctry:US

or even limit it to more med-chem relevant patent hits by using the appropriate IPC hierarchical classification codes:

(ttl:diabetes OR ab:diabetes) AND ic:(C07D AND (A61K OR A61P)) AND pdyear:2014 AND pnctry:US

Is that all? No, you could also use wildcards, such as * and ?, as well as proximity searches:

(ttl:diabet* OR ab:diabet*) AND pdyear:2014 AND pnctry:US

A couple of thing worth pointing out here:
1) in the way described above, you may search not only the chemically-annotated (EP, US, WO, JP patents) or chemically-relevant corpus but any patent within SureChEMBL’s broad coverage, such as French, German, British, Chinese, Australian, Canadian, etc., patents about any topic:

pa:"Apple Inc" AND ab:vehicle AND pnctry:CN

for such cases, just remember to check the 'All authorities' box on the right hand side panel.
2) If the Lucene query syntax seems too complicated, almost the same functionality is available via a more user-friendly field-based widget called Fielded Search:
  

ChemAxon-powered structure searching

To begin with, SureChEMBL provides basic substructure and similarity searches against the currently 17 million chemical structures, powered by ChemAxon’s JChem technology. Some of you may have noticed that we have recently done some refurbishment around the sketchers and we now provide the latest MarvinJS sketcher as the sole source of structure input. We also removed the manual entry box, as it is superseded by functionality described below. Behind the scenes, we use the native ChemAxon inter-conversion functionality to ensure maximum compatibility and minimum information loss during structure conversions. The good news is that you can input a structure in several ways (besides sketching it from scratch), e.g. SMILES, SMARTS, CML, InChI, Molfile and IUPAC/trivial name. Just click and paste your string on the MarvinJS sketcher or open the import dialogue to paste it right there - or even upload a file. More importantly, you may now take advantage of more advanced query features, such as (NOT) atom and bond lists, explicit hydrogens, as well as the Markush-friendly position variation and repetition ranges.

For example, this is a query that combines atom, not atom, and bond lists, as well as explicit hydrogens to control substitution:


Or this one, which combines position variation and linker repetition range:


Again, don't forget that you have additional control over the MW range of the search hits, as well as their exact location in the patent document (title, abstract, claims, description, images/molfiles).


Combined keyword and structure searching

Finally, as mentioned in the beginning, you can easily submit combined keyword and structure queries, such as this one:


...to our knowledge, there's no other freely available patent searching resource or interface out there providing this type of functionality but we're happy to stand corrected...

As usual, for any questions or feedback, drop us a line.


George and Nathan

Comments

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d